Dreman Value Management’s Pfizer PFE Stock Holding History

Dreman Value Management’s Portfolio PFE Stock Details PFE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q1	$512K	Hold	15,203	–	–	0.23%	104
2017 Q4	$522K	Sell	15,203 -15,584	-51%	-$531K	0.29%	94
2017 Q3	$1.04M	Hold	30,787	–	–	0.57%	53
2017 Q2	$981K	Buy	30,787 +10,865	+55%	+$343K	0.54%	60
2017 Q1	$647K	Hold	19,922	–	–	0.37%	73
2016 Q4	$614K	Sell	19,922 -11,658	-37%	-$356K	0.34%	76
2016 Q3	$1.01M	Hold	31,580	–	–	0.62%	52
2016 Q2	$1.05M	Buy	31,580 +25,446	+415%	+$812K	0.65%	50
2016 Q1	$173K	Buy	+6,134	New	+$175K	0.02%	277
2015 Q4	–	Sell	-6,791	Closed	-$202K	–	354
2015 Q3	$202K	Sell	6,791 -19,481	-74%	-$625K	0.02%	310
2015 Q2	$836K	Sell	26,272 -291	-1%	-$9.48K	0.07%	218
2015 Q1	$877K	Buy	26,563 +10,972	+70%	+$349K	0.08%	208
2014 Q4	$461K	Sell	15,591 -261	-2%	-$7.48K	0.04%	227
2014 Q3	$445K	Buy	15,852 +1,502	+10%	+$42.2K	0.04%	230
2014 Q2	$404K	Buy	14,350 +1,859	+15%	+$53K	0.03%	239
2014 Q1	$381K	Buy	12,491 +1,779	+17%	+$53K	0.03%	224
2013 Q4	$311K	Sell	10,712 -64,328	-86%	-$1.87M	0.02%	234
2013 Q3	$2.04M	Buy	+75,040	New	+$2.04M	0.18%	203

Other funds holding PFE

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Dreman Value Management's PFE Position: Q1 2018 in Review

Dreman Value Management held its Pfizer (PFE) position steady in Q1 2018 at 15,203 shares worth $512K. The position accounts for 0.23% of the portfolio, ranked #104.

Dreman Value Management first reported a position in PFE in Q3 2013 and has held it in 18 quarters since. The position peaked at $2.04M in Q3 2013. 2,229 funds tracked by Wall St. Rank hold PFE as of Q1 2018.

Dreman Value Management held 15,203 shares of Pfizer worth $512K as of Q1 2018.
Dreman Value Management left its Pfizer share count unchanged in Q1 2018.
Pfizer made up 0.23% of Dreman Value Management's portfolio in Q1 2018, its #104 holding.
Dreman Value Management first reported a position in Pfizer in Q3 2013 and has held it in 18 quarters since.
Dreman Value Management's Pfizer position peaked at $2.04M in Q3 2013.
2,229 funds tracked by Wall St. Rank held Pfizer as of Q1 2018.

Based on Dreman Value Management's 13F filing for Q1 2018, filed 2 May 2018.